Prostate News Archive
29-Jun-2008
Prostate Cancer Characteristics Of Potential Candidates For Active Surveillance After Initial And Repeat Biopsy (Medical News Today)
ORLANDO, FL (UroToday.com) - Active surveillance (AS) is a treatment option in patients diagnosed with low risk prostate cancer. Several recommendations for identification of low risk cancers are published and a repeat biopsy during AS plays a key role in such schemes. Characteristics of men suitable for active surveillance according to published protocols are presented (1-6 below). Risk And Predictors Of Prostate Cancer In Men With Negative Repeat Saturation Biopsy (Medical News Today)
ORLANDO, FL (UroToday.com) - These investigators sought to determine both the risk of future prostate cancer in patients that undergo negative repeat saturation biopsies and the criteria that should be used in decision making whether to do follow-up biopsy in a patient with a previous negative repeat saturation or not. ABC News NIGHTLINE Features HIFU with Sonablate(R) 500 as Non Invasive Treatment Option for Prostate Cancer (Broadcast Newsroom)
CHARLOTTE, N.C. , June 27 /PRNewswire/ -- USHIFU, LLC, the exclusive distributor of the minimally invasive Sonablate(R) 500 for prostate cancer treatment in North and South America , announced that the June 16, 2008 edition of ABC News NIGHTLINE featured a segment on high intensity focused ultrasound (HIFU) for treating prostate cancer outside of the United States using the Sonablate(R) 500.
Back to Prostate News Archive
